All News

Here are highlights of important safety information regarding Fentora

The National Governors Association will recommend that a cross-state cooperative pharmacist licensure system be created so that pharmacists can practice across state/territorial lines.

Drug Topics profiles Schnucks Pharmacy, chain of the year for 2008

What are the current prescribing trends and controversial issues that impact pediatric therapeutic management?

Pharmacies fight back after pressure from the Drug Enforcement Administration has forced Cardinal Healthcare and other wholesaler drug distributors to implement systems to stop drug diversion

States issue guidelines for the April 1st implementation of Medicare's tamper-resistant prescription pad rule

Because of cardiovascular and gastrointestinal risks, NSAIDS are no longer recommended for long-term use. No single drug or therapy is regarded as the ideal long-term treatment for osteoarthritis.

Wyeth will begin marketing its new serotonin-norepinephrine reuptake inhibitor.

Thirteen percent of all eligible prescriptions are transmitted electronically in Massachusetts.

Students need grounding in chemistry

Here is a listing of brand pharmaceuticals that will lose their patents through 2009.

Cubist Pharmaceuticals finds impurity in reconstituted daptomycin

Pfizer revises package insert after reports of lung cancer in patients receiving their inhaled insulin.

DEA is proposing to consider ANPP as a precursor to fentanyl and to classify it as a Schedule II controlled substance.

The FDA and Institute for Safe Medication Practices report that many drug errors are still occurring with Cerebyx because many hospital staffers are misreading the drug concentration.

Walter Jones has received the endorsement from the National Community Pharmacists Association in his primary battle for the rural North Carolina House district.

Rite Aid is partnering with MedStar Health and Consumer Health Services to launch in-store clinics in select Rite Aid stores.

HospiScript Services, a provider of pharmacy medication therapy management services to hospices has been acquired by HealthExtras

The Midwest wholesaler McQueary Brothers has agreed to be acquired by McKesson Corp.for $190 million.

Novartis is set to pay as much as $39 biliion to buy a controlling stake in Alcon, a Houston company that dominates the eye care market.

Bristol-Myers Squibb granted approval for arthritis biologic Orencia.

Comprehensive Pharmacy Services to buy McKesson Medication Management.

WellPoint Next Rx pilots OTC generic program with Blue Cross & Blue Shield of Rhode Island to help offset out-of-pocket costs for members.

Eisai has produced a report on how seniors feel about their pharmacy, drug plan, and related subjects.

A Drug Topics survey finds that most think FDA could use more funding to redress its deficiencies.

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

Federal agents seize over $1.3 million of illegal dietary supplements marketed to body builders.

Several more chains launch $4 generics, including Ralphs and Fred Meyer.

Shire launches initiative for chronic kidney disease patients.

A listing by the New York Times shows that CVS' CEO made more than $17 million and Walgreens' CEO made more than $5 million last year.